INITIAL RESULTS OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH DOSE‐ADJUSTED R‐EPOCH FOR PATIENTS WITH RICHTER'S SYNDROME (CRC‐043). (12th June 2019) - Davids, M.S.; Thompson, P.A.; Rogers, K.A.; Tyekucheva, S.; Pazienza, S.; Francoeur, K.; Renner, S.K.; Bazemore, J.; Rocchio, M.; Ihuoma, U.; Jacobson, C.A.; Fisher, D.C.; et al.